However, the drug's makers, Abbott Laboratories of the US, point out that at present nine million people worldwide take Reductil, but only 34 have died from taking the drug. The death rate among users is only two per 100,000, far lower than the natural death rate of 400 per 100,000 among obese people.
美國亞培藥廠則指出，目前全球約有九百萬人服用諾美婷，總計，約有三十四名病患因服用該藥後死亡，死亡率僅達十萬分之二，遠低於肥胖者每十萬人有四百人的自然死亡率。